Michael sits down with The Patent Lawyer to discuss the importance of developing a robust intellectual property portfolio in rapidly evolving technologies like CRISPR/Cas9, the considerations for maintaining a global patent portfolio, and the importance of having the correct IP in place to protect product development timelines and ensure the ability to commercialize.

Dr Dustin Bauer, Associate at Reddie & Grose LLP, enters the trade secret vs. patents debate, analyzing the recent case between Tesla and its supplier to evaluate the advantages and potential drawbacks of each type of protection.

Sophie Ertl and Heike Röder-Hitschke of Maiwald evaluate the first 15 months of the Unitary Patent Court to assess its success in comparison to the EPO system, whilst providing guidance for leveraging the best available protection.

Robert Klinski, Founder of Patentship, analyses how to harvest valuable inventions to develop sustainable IP portfolios in digital technologies.

David McCombs, Eugene Goryunov, and Eric Horsley of Haynes & Boone review recent cases that have questioned public accessibility to provide best practice advice for indexing and searchability.

Yingan Gu, patent attorney of Beijing Sanyou IP Agency Ltd., identifies relevant laws and regulations surrounding parameters in patent examination whilst reviewing recent trends with case examples.

Rommy Morales, Sergio Olivares, Daniel Sánchez, and Jorge Juarez of OLIVARES introduce the changes set out in WIPO Standard ST.26, including new rules for representing amino acids and nucleotides and the need for applicants to adjust in preparing and submitting patent applications.

Alina Tugearu, Partner at Zamfirescu Racoti Vasile & Partners, details the enforcement of provisional measures for patent infringement and the concept of fault-based liability.

Featuring: Xiyin Tang, Professor of Law at UCLA

Sponsored by: Clarivate

Featuring:Kisha Iles: Senior Manager of IP Information Management, Johnson & Johnson

Sponsored by: Clarivate

10 of the best law firms from each of the top Asia Pacific jurisdictions, including China, India, and Japan.

Koji Sugimura and Takuya Izumi of Sugimura & Partners provide an overview of the questions solicited by third parties around the industrial applicability requirement and the historical development and current status of the patent requirement in the medical field.

Olga Dolgikh, Patent Advisor to the Managing Partner at Zuykov and partners, details the procedure for ownership transfer in line with relevant legislation in her jurisdiction.

Pravin Anand, Vaishali Mittal, and Siddhant Chamola of Anand and Anand dive into the significant developments in Indian patent law over the past year, exploring major case outcomes, evolving legal principles, and new legislative changes that have shaped the patent landscape in the region.

Anton Melnikov, Senior Lawyer at Gorodissky & Partners, delves into the legal and financial consequences of exploiting patents without the owner’s consent and examines the application of competition protection law in such cases.

Esau Andrade, Patent Practitioner at Dumont, discusses the recent interpretation and practice of the MPO regarding sufficiency and credibility requirements, exploring how the practice aligns with concepts from the USPTO and the EPO.

Alexey Vakhnin, Partner and Managing Director of Vakhnina and Partners, sits down with Dr. Grigory Ivliev, the EAPO President, to discuss the EAPO’s achievements over the past 30 years along with future goals and aspirations.

Ranjan Narula and Suvarna Pandey of RNA Technology and IP Attorneys raise key points around the role of a person skilled in the art of determining patentability, drawing on recent cases related to inventive step and patent eligibility under section 3(k) of the India Patent Act.

David Aylen and Rachel Armstrong of Gowling WLG discuss patents in the UAE, highlighting the basics for establishing a strong application and the balance between enforcement and tech transfer.